154 related articles for article (PubMed ID: 20124619)
1. The therapeutic potential of RNA interference in controlling HIV-1 replication.
Soejitno A; Wihandani DM; Kuswardhani T
Acta Med Indones; 2009 Oct; 41(4):215-21. PubMed ID: 20124619
[TBL] [Abstract][Full Text] [Related]
2. Control of HIV-1 replication by RNA interference.
Lee NS; Rossi JJ
Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
[TBL] [Abstract][Full Text] [Related]
3. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O; Konstantinova P; Ceylan M; Berkhout B
Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
[TBL] [Abstract][Full Text] [Related]
4. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.
Leonard JN; Schaffer DV
J Virol; 2005 Feb; 79(3):1645-54. PubMed ID: 15650190
[TBL] [Abstract][Full Text] [Related]
5. The future of HIV infection: gene therapy and RNA interference.
Delgado R; Regueiro BJ
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():68-83. PubMed ID: 16373006
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.
Christensen HS; Daher A; Soye KJ; Frankel LB; Alexander MR; Lainé S; Bannwarth S; Ong CL; Chung SW; Campbell SM; Purcell DF; Gatignol A
J Virol; 2007 May; 81(10):5121-31. PubMed ID: 17360756
[TBL] [Abstract][Full Text] [Related]
7. Suppression of HIV replication using RNA interference against HIV-1 integrase.
Lau TS; Li Y; Kameoka M; Ng TB; Wan DC
FEBS Lett; 2007 Jul; 581(17):3253-9. PubMed ID: 17592732
[TBL] [Abstract][Full Text] [Related]
8. [RNA interference and its application in inhibiting HIV-1 infection].
Wei L; Liu X; Cao C
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):516-9. PubMed ID: 16176084
[TBL] [Abstract][Full Text] [Related]
9. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
[TBL] [Abstract][Full Text] [Related]
10. RNA interference and HIV-1 infection.
Kanzaki LI; Ornelas SS; Argañaraz ER
Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.
Westerhout EM; Ooms M; Vink M; Das AT; Berkhout B
Nucleic Acids Res; 2005; 33(2):796-804. PubMed ID: 15687388
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of drug-resistant HIV-1 by RNA interference.
Huelsmann PM; Rauch P; Allers K; John MJ; Metzner KJ
Antiviral Res; 2006 Jan; 69(1):1-8. PubMed ID: 16290277
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
[TBL] [Abstract][Full Text] [Related]
14. HIV-1-specific RNA interference.
Boden D; Pusch O; Ramratnam B
Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
[TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
16. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
17. Potential applications of siRNA in hepatitis C virus therapy.
Smolic R; Volarevic M; Wu CH; Wu GY
Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.
Senserrich J; Pauls E; Armand-Ugón M; Clotet-Codina I; Moncunill G; Clotet B; Esté JA
Virology; 2008 Mar; 372(2):421-9. PubMed ID: 18068205
[TBL] [Abstract][Full Text] [Related]
20. RNA interference as a tool for exploring HIV-1 robustness.
Nevot M; Martrus G; Clotet B; Martínez MA
J Mol Biol; 2011 Oct; 413(1):84-96. PubMed ID: 21875599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
